Drugs / Pancreatin Enteric-coated Capsules
Pancreatin Enteric-coated Capsules
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06119880 | Nov 2023 → Dec 2024 | exocrine pancreatic insufficiency | Ruijin Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Pancreatin Enteric-coated Capsules | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06119880 ↗ |
| Modality | Protein / enzyme biologic | “pancreatic enzyme replacement therapy” NCT06119880 ↗ |